Frank Condella has over 30 years of experience in executive roles within the pharmaceutical industry.
His operating experience includes being chief executive of Juniper Pharmaceuticals, a US public-listed CDMO and specialty pharmaceutical company which was sold to Catalent. He was also chief executive of Skyepharma, president of European operations at IVAX (Teva), chief executive of Faulding Pharmaceuticals, vice president of Specialty Care Products at Roche, and vice president & general manager of the Lederle Standard Products (Pfizer).